Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies: GlobalData Read more
Blockchain For Impact announces USD 15 million fund for biomedical research and innovation in India Read more
Large pharma cos to invest nearly 7 per cent revenue on next-gen labs by 2025: Capgemini report Read more
Suven announces randomisation of first patient in Phase-2 POC clinical trial of Ropanicant (SUVN-911) Read more
PDC*line Pharma, partners get €8.1mn from Walloon region, BioWin for personalised therapeutic vaccine Read more